Key facts
- Enstem’s last known valuation is $10.8M (Jun 2025).
- It has raised $3.1M; the latest was Later Stage VC ($1.7M) in Jun 2025.
- Notable investors include Rakuten Capital, Inclusion Japan, Mercuria Investment Company, Nagase, Nagase & Co. — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Enstem
- ·The full record, as it builds
Funding rounds
No funding rounds for Enstem are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Enstem
Developer of a personal performance management application designed for individuals to analyze body data. The company's application analyzes subjective data acquired from a dedicated smartwatch and quantifies the condition, enabling people to track their health data and make informed decisions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Tokyo, Japan
- Founded
- 2019
- Employees
- 17
- Website
- en-stem.co.jp/
- Ownership
- Privately Held (backing)
Enstem doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Enstem shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Enstem in its N-PORT filings yet. We sweep new filings monthly.